Clinical Trial Update: Compare the Effect of DPP-IV Inhibitor or TZD on Glycemic Variability and Oxidative Stress in Patient With 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing a DPP-4 inhibitor with a thiazolidinedione to assess effects on glycemic variability and oxidative stress in patients with type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)
• Januvia (sitagliptin) (sitagliptin)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Diabetes Mellitus, Oxidative Stress | Phase 4 | Status: UNKNOWN